4//SEC Filing
Habig Scott Michael 4
Accession 0001628280-22-019949
CIK 0001600620other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:13 PM ET
Size
7.5 KB
Accession
0001628280-22-019949
Insider Transaction Report
Form 4
Habig Scott Michael
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-01+231,203→ 231,203 totalExercise: $8.18Exp: 2032-08-01→ Common Stock (231,203 underlying) - Award
Restricted Stock Units
2022-08-01+137,531→ 137,531 total→ Common Shares (137,531 underlying)
Footnotes (2)
- [F1]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001938159
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:13 PM ET
- Size
- 7.5 KB